Protagonist Therapeutics, Inc.
METHODS FOR DETERMINING AND MONITORING GASTROINTESTINAL INFLAMMATION

Abstract:

The present invention provides methods for determining levels of biomarkers of inflammation in samples from human patients, e.g., patients undergoing treatment with a peptide inhibitor of interleukin-23 receptor. Such methods are useful, for example, in monitoring the therapeutic effect of treatment of an inflammatory disease or disorder with a peptide inhibitor of interleukin-23 receptor.